Gesellschaftsrecht / M&A

Kapitalmarkt

Wettbewerb

Steuern

Healthcare / Life Sciences

Homburger News

Homburger advises PolyPeptide in connection with the all-cash public tender offer launched by Samsung Biologics to acquire all publicly held registered shares of PolyPeptide

On July 20, 2026, PolyPeptide Group AG (SIX: PPGN), a specialized global Contract Development &amp; Manufacturing Organization (CDMO) for peptide-based active pharmaceutical ingredients, and Samsung Biologics Co., Ltd. announced that they have entered into a transaction agreement under which Samsung Biologics agreed to make an all-cash public tender offer to acquire all publicly held registered shares of PolyPeptide for CHF 44.31 per share. The offer values PolyPeptide’s equity at approximately CHF 1.46 bn. Samsung Biologics published its pre-announcement of the offer today. PolyPeptide’s largest individual shareholder, owning a stake of approximately 55.65% (excluding treasury shares), has committed to tender all of its shares into the offer.
The offer is subject to the satisfaction of customary offer conditions, including a minimum acceptance rate of 66.67% on a fully diluted share count basis and the receipt of regulatory approvals in certain jurisdictions.
Homburger is acting as legal counsel to PolyPeptide Group AG in connection with the transaction. The Homburger team is led by Frank Gerhard and included Micha Fankhauser, Nicola Togni, Patrick Schmidt, Matthias Müller, Pepe Hünerwadel, Matteo Gasser and Filippo Moggi (all Corporate / M&amp;A, Capital Markets), Richard Stäuber, Allegra Arnold and Anna-Katharina Leitz (all Competition), as well as Stefan Oesterhelt (Tax).

IP / IT

Datenschutz

Arbeitsrecht und Vergütung für Führungskräfte

Scaled-Agile-web-640x140

Homburger and Scaled Agile

On April 20, 2023, Scaled Agile Inc., a portfolio company of Eurazeo SE (Euronext Paris: RF), one of Europe&#8217;s leading private equity firms, announced its acquisition of Rentouch, a Swiss-based company specializing in software for visualizing agile planning events across multiple agile teams with SAFe®. This acquisition aims to accelerate Scaled Agile&#8217;s goal to redefine the way the world&#8217;s leading organizations identify and deliver customer value, capitalize on emerging opportunities, and improve business outcomes through integrated solutions that help teams unlock better ways of working.
Homburger advised Scaled Agile in this transaction. The team was led by Dieter Gericke (Corporate/M&amp;A) and included Léonard Aeschlimann (Corporate/M&amp;A), Reto Heuberger, Philippe Weber (both Tax), Gabriel Kasper (IP/IT and Data Protection), Matia Trosic and Frédéric Fitzi (both Employment and Executive Compensation) as well as Pepe Hünerwadel and Florian Gasche (both Corporate/M&amp;A).

Homburger advises Scaled Agile on its acquisition of Rentouch

Solenis

Homburger and Solenis

On March 8, 2023, Solenis announced that it has entered into a definitive merger agreement under which Solenis will acquire Diversey in an all-cash transaction valued at an enterprise value of approximately USD 4.6 bn. Upon completion of the merger, Diversey will become a private company.
Headquartered in Wilmington, Delaware, Solenis is a leading manufacturer of specialty chemicals used in water-intensive industries, which was acquired by Platinum Equity in 2021. Diversey is a leading provider of hygiene, infection prevention and cleaning solutions based in Fort Mill, South Carolina.
The transaction is expected to be completed in the second half of 2023, subject to customary closing conditions.
Homburger acts as Swiss transaction counsel to Solenis. The Homburger team includes Andreas Müller, Karin Mattle and Pepe Hünerwadel (all Corporate / M&amp;A), Kristina Martinovic (Employment and Executive Compensation) as well as Gregor Bühler and Hélène Bruderer (both IP / IT).

Pepe
Hünerwadel

Homburger advises PolyPeptide in connection with the all-cash public tender offer launched by Samsung Biologics to acquire all publicly held registered shares of PolyPeptide

Homburger advises Scaled Agile on its acquisition of Rentouch

Homburger advises Solenis on the acquisition of Diversey

Join the Team

Pepe Hünerwadel

Karriere

Sprachen

Zulassung

Teams

PepeHünerwadel

Homburger advises PolyPeptide in connection with the all-cash public tender offer launched by Samsung Biologics to acquire all publicly held registered shares of PolyPeptide

Homburger advises Scaled Agile on its acquisition of Rentouch

Homburger advises Solenis on the acquisition of Diversey

Join the Team

Pepe Hünerwadel

Karriere

Sprachen

Zulassung

Teams

Pepe
Hünerwadel